Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Biden admin won't veto ITC's Apple Watch import ban ruling

Published 2023-02-21, 02:20 p/m
© Reuters. FILE PHOTO: An attendee holds two titanium Apple Watch Edition smart watches in the demonstration area during a launch event at their headquarters in Cupertino, California, U.S., September 10, 2019. REUTERS/Stephen Lam

By Blake Brittain

(Reuters) -The Biden Administration will not overrule a U.S. International Trade Commission decision that could block imports of Apple Inc (NASDAQ:AAPL)'s Apple Watches for infringing AliveCor Inc patents related to heart monitoring, the office of the U.S. Trade Representative said Tuesday.

An AliveCor spokesperson also said it had been informed there would be no veto of the ruling. Any ITC ban is still on hold while Apple and AliveCor continue to clash over the patents.

The ITC ruled in December that imports of Apple's smartwatches should be banned for infringing AliveCor's patents, but it placed the ban on pause while related proceedings over the patents run their course. The U.S. Patent and Trademark Office found the patents invalid earlier that month, in a ruling that AliveCor has said it will appeal.

Apple said Tuesday it will appeal the ITC's import ban decision, which it said would have a negative effect on public health.

Representatives for the White House did not immediately respond to a request for comment Tuesday. The ITC had no comment.

The White House had 60 days to decide whether to veto the ITC's Dec. 22 ruling based on policy concerns.

Presidential vetoes of ITC import bans have historically been rare. However, the Obama administration reversed a ban on some iPhones and iPads in 2013 in a patent fight between Apple and Samsung Electronics (KS:005930) Co Ltd, citing its effects on U.S. consumers and economic competition.

AliveCor accused Apple of infringing three patents related to its KardiaBand, an Apple Watch accessory that monitors a user's heart rate, detects irregularities and performs an electrocardiogram to identify heart problems like atrial fibrillation.

Mountain View, California-based AliveCor told the ITC that Apple copied its technology and drove it out of the market by making Apple's operating system incompatible with the KardiaBand.

Apple Watch Series 4, 5, 6, 7, and 8 have ECG technology. Apple introduced its most recent Series 8 last year.

AliveCor has separately sued Apple in California federal court for allegedly monopolizing the U.S. market for Apple Watch heart-rate apps, and filed a related patent infringement lawsuit against Apple in Texas federal court.

© Reuters. FILE PHOTO: An attendee holds two titanium Apple Watch Edition smart watches in the demonstration area during a launch event at their headquarters in Cupertino, California, U.S., September 10, 2019. REUTERS/Stephen Lam

Apple has countersued AliveCor in San Francisco federal court for allegedly infringing its patents.

The ITC case is Certain Wearable Electronic Devices With ECG Functionality and Components Thereof, U.S. International Trade Commission, No. 337-TA-1266.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.